Zhuangzhuang Liang
State Key Laboratory Of Natural Medicines, #24 Tong Jia Xiang Street, P.R. China
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
FDCA Attenuates Neuronal Ferroptosis and Reduces Hemorrhagic Transformation After Ischemic Stroke with High Glucose.
Journal: Cellular and molecular neurobiology
Published: June 11, 2025
Design, Synthesis, and Anti-ischemic Stroke Activity Evaluation of Novel GSNOR Inhibitors.
Journal: Journal of medicinal chemistry
Published: June 10, 2025
A Fluorescent Probe for Imaging and Treating S-Nitrosation Stress in OGD/R Cells.
Journal: Antioxidants (Basel, Switzerland)
Published: January 14, 2025
FDCA Attenuates Neuroinflammation and Brain Injury after Cerebral Ischemic Stroke.
Journal: ACS chemical neuroscience
Published: September 28, 2023
Exploring the immunomodulatory effects and mechanisms of Xinjiang fermented camel milk-derived bioactive peptides based on network pharmacology and molecular docking.
Journal: Frontiers in pharmacology
Published: September 07, 2022
Protein S-Nitrosation: Biochemistry, Identification, Molecular Mechanisms, and Therapeutic Applications.
Journal: Journal of medicinal chemistry
Published: April 12, 2022
Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells.
Journal: Drug design, development and therapy
Published: December 17, 2020
A novel PGAM5 inhibitor LFHP-1c protects blood-brain barrier integrity in ischemic stroke.
Journal: Acta pharmaceutica Sinica. B
Published: August 23, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026